⚙
AI-generated deep summary
by claude@2026-07, 2026-07-06
· read from full text
ⓘ
This paper reviews and investigates plasma microRNA (miRNA) expression as potential biomarkers for endometriosis diagnosis. Using a convenience sample of 22 women (15 with endometriosis confirmed by imaging or laparoscopy, and 7 controls), the study quantified relative miRNA expression by RT-qPCR and evaluated diagnostic discrimination with ROC curves, logistic regression, and decision trees. The authors report that the studied miRNA panel shows significant discriminatory ability as an adjunct to existing diagnostic approaches and suggest it could support future targeted molecular therapies. A major limitation explicitly noted is the need for confirmation of clinical relevance in larger-scale studies. This paper is centrally about endometriosis — plasma miRNA panels for more precise diagnosis and potential therapeutic directions.
Abstract
“Endometriosis is a condition marked by the abnormal growth of tissue similar to the endometrium outside the uterus, impacting approximately 10% of women of reproductive age and leading to infertility as well as severe menstrual pain. Diagnosing this condition remains a complex endeavor, as symptoms are frequently dismissed as normal. Although laparoscopy has traditionally been regarded as the definitive diagnostic method, specialized ultrasound and magnetic resonance imaging (MRI) have emerged as effective alternatives. Nonetheless, the identification of specific molecular biomarkers is crucial for enhancing early detection and making diagnosis more accessible. In our research, we examined the expression levels of miRNAs in plasma samples from 22 women, employing a non-probabilistic convenience sampling strategy. The relative expression of miRNAs was quantified using RT-qPCR, and the data were analyzed through individual and cumulative ROC curves, logistic regression, and decision trees. Participants were categorized into two groups: those diagnosed with endometriosis (n=15) and a control group (n=7), with diagnoses verified through imaging or laparoscopy. Our findings indicate that the miRNA panel we studied demonstrates significant discriminatory ability, making it a potential adjunct to existing diagnostic techniques. Furthermore, this research paves the way for the development of targeted molecular therapies, which could revolutionize the clinical management of endometriosis and provide more effective treatment options in the future. Confirming its clinical relevance through larger-scale studies will be essential for validating its use in both diagnosis and treatment.”
Full text
2,127 characters
· extracted from
oa-doi-fallback
· click to expand
Review of the Abstract: miRNAs in Endometriosis: Towards Precise Diagnosis and New Therapeutic Approaches
Authors/Creators
Description
“Endometriosis is a condition marked by the abnormal growth of tissue similar to the endometrium outside the uterus, impacting approximately 10% of women of reproductive age and leading to infertility as well as severe menstrual pain. Diagnosing this condition remains a complex endeavor, as symptoms are frequently dismissed as normal. Although laparoscopy has traditionally been regarded as the definitive diagnostic method, specialized ultrasound and magnetic resonance imaging (MRI) have emerged as effective alternatives. Nonetheless, the identification of specific molecular biomarkers is crucial for enhancing early detection and making diagnosis more accessible.
In our research, we examined the expression levels of miRNAs in plasma samples from 22 women, employing a non-probabilistic convenience sampling strategy. The relative expression of miRNAs was quantified using RT-qPCR, and the data were analyzed through individual and cumulative ROC curves, logistic regression, and decision trees. Participants were categorized into two groups: those diagnosed with endometriosis (n=15) and a control group (n=7), with diagnoses verified through imaging or laparoscopy.
Our findings indicate that the miRNA panel we studied demonstrates significant discriminatory ability, making it a potential adjunct to existing diagnostic techniques. Furthermore, this research paves the way for the development of targeted molecular therapies, which could revolutionize the clinical management of endometriosis and provide more effective treatment options in the future. Confirming its clinical relevance through larger-scale studies will be essential for validating its use in both diagnosis and treatment.”
Files
Files
(21.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:223226c5f5c30ac67f8f5473afc9734f
|
21.0 kB | Download |
Additional details
Identifiers
Software
- Repository URL
- https://makedonskaia.org/v
- Programming language
- HTML , Python , CSS
- Development Status
- Active
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.